Skip to Content
Merck
  • Itraconazole treatment of nonmeningeal coccidioidomycosis in children: two case reports and review of the literature.

Itraconazole treatment of nonmeningeal coccidioidomycosis in children: two case reports and review of the literature.

The Pediatric infectious disease journal (2009-11-04)
James D Homans, LaShonda Spencer
ABSTRACT

Coccidioides immitis causes a wide range of disease in humans. Fluconazole and itraconazole are effective treatments. Clinical evidence suggests that itraconazole is equivalent or superior to fluconazole in treating osteoarticular infections in rates of cure and recurrence. We report 2 cases of coccidioidomycosis involving bone in children successfully treated with itraconazole oral solution. Itraconazole oral solution is effective in treating nonmeningeal coccidioidomycosis in children, particularly skeletal disease, and infections that are refractory to fluconazole.

MATERIALS
Product Number
Brand
Product Description

Supelco
Itraconazole solution, 2.0 mg/mL (Methanol with 1% 1M HCl), ampule of 1 mL, certified reference material, Cerilliant®
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Itraconazole, ≥98% (HPLC)
SKU
Pack Size
Availability
Price
Quantity
Itraconazole for system suitability, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Itraconazole, European Pharmacopoeia (EP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity